Protective composite amino acid composition for kidney and its use
A composition and amino acid technology, applied in the pharmaceutical field, in the field of nephroprotective branched-chain amino acid compositions, can solve problems such as the unexplained mechanism of amino acid protection, increase glomerular filtration rate, improve respiratory disorders , the protective effect of oxidative phosphorylation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0023] Preparation of the composition of the present invention: weigh 5.5 grams of glycine, 7.5 grams of L-alanine, 0 grams of L-threonine, 7.5 grams of L-serine, 5 grams of L-valine, and 5 grams of L-leucine , 2 grams of L-isoleucine and 5 grams of L-proline were dissolved in 500 ml of 0.45% NaCl, and the pH value of the solution was adjusted to 6.5 with NaOH and HCl.
Embodiment 2
[0025] Protective effect of amino acid mixture on cisplatin-induced acute renal failure in rats
[0026] Experimental model: select male SD rats with a body weight of 250-350g, divide into 4 groups, control group (n=16): intravenous infusion of 0.9% sodium chloride 2ml, and then maintain the speed of 2ml / h; cisplatin group (n=12): After intravenous infusion of 0.9% sodium chloride 2ml, receive 10mg / kg cisplatin (10mg / ml), and continue intravenous infusion of sodium chloride solution at 2ml / h; cisplatin + amino acid group (n=10) intravenous infusion of 8 kinds of L-amino acids After 2ml of mixture, give 10mg / kg cisplatin, followed by amino acid 2ml / h; amino acid group (n=16): after intravenous infusion of 2ml of 8 kinds of L-amino acid mixture, maintain at 2ml / h. Anesthetized by intraperitoneal injection of pentobarbital sodium 60mg / kg, the body temperature was maintained at 37C. A dual-channel venous infusion set was inserted into the femoral vein on one side for liquid inject...
Embodiment 3
[0033] Protective effect of amino acid mixture on renal ischemia-reperfusion injury in rats.
[0034] 1. Preparation of the composition of the present invention: weigh 7.5 grams of glycine, 5.5 grams of L-alanine, 2.0 grams of L-threonine, 7.5 grams of L-serine, 5 grams of L-valine, and 5 grams of L-leucine 2 grams, 0 grams of L-isoleucine, and 6.5 grams of L-proline were dissolved in 500 ml of 0.45% NaCl, and the pH value of the solution was adjusted to 6.5 with NaOH and HCl.
[0035] 2. Experimental scheme Twenty-four healthy adult male Sprague-Dawley rats, weighing (230±18) g. Randomly divided into group A: sham operation group, group B: control group, group C: treatment group. 8 in each group. Anesthetized by intraperitoneal injection of 2% pentobarbital sodium 60mg / kg. The left femoral vein was intubated and connected to a micropump for continuous infusion of normal saline (groups A and B) or amino acid mixture (group C) with a fluid infusion rate of 1ml·100g -1 h -1...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com